Nutex Health (NASDAQ:NUTX) Stock Price Up 15.3% After Strong Earnings

Nutex Health Inc. (NASDAQ:NUTX) rose 15.3% on Friday after the company announced better than expected quarterly earnings. The stock traded as high as $140.74 and last traded at $137.3850. Approximately 79,310 shares were traded during trading, a decline of 60% from the average daily volume of 196,113 shares. The stock had previously closed at $119.20.

The company reported $6.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. The firm had revenue of $216.49 million for the quarter, compared to the consensus estimate of $227.80 million. Nutex Health had a return on equity of 17.67% and a net margin of 7.34%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Saturday, March 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a report on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Institutional Trading of Nutex Health

A number of hedge funds and other institutional investors have recently bought and sold shares of NUTX. State of Alaska Department of Revenue purchased a new stake in Nutex Health in the third quarter worth about $30,000. Islay Capital Management LLC purchased a new stake in Nutex Health in the fourth quarter worth about $34,000. BNP Paribas Financial Markets increased its position in Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after buying an additional 290 shares in the last quarter. Royal Bank of Canada grew its position in shares of Nutex Health by 752.4% during the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after purchasing an additional 316 shares in the last quarter. Finally, Bank of America Corp DE raised its stake in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after purchasing an additional 2,043 shares during the period. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Price Performance

The firm has a 50 day moving average of $102.21 and a 200-day moving average of $126.29. The company has a market cap of $958.62 million, a P/E ratio of 15.27 and a beta of 0.10. The company has a current ratio of 3.41, a quick ratio of 3.39 and a debt-to-equity ratio of 0.70.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.